title: [Pharmacokinetic monitoring of aminoglycoside therapy: an optimal method of administration of individualized doses of gentamicin and sisomicin].
abstract: One of the most promising approaches to design the optimal schedule for TDM provides a single determination of a drug content in the blood specimen being collected at the "ideal" sampling time equaled to the inverse value of the elimination rate constant. Three versions of the one-point method when the specimen was collected at the "ideal" time point (3 h after a single i.m. drug administration), as well as at the times of "maximum" (1 h after injection) and "minimum" (6 h after injection) concentrations were compared by the retrospective analysis of the routine TDM data obtained with HPLC-techniques in 47 patients treated with gentamicin or sisomicin. As optimal individualized doses were considered ones calculated on the base of three subsequent determinations of the aminoglycoside concentrations, i.e. 1, 3 and 6 h after injection, and the estimation of individual clearance values (Cli). The optimal doses (DCl) were calculated according to equation DCl = Dp.Cli/Clp, where Dp and Clp are population values of the dose (1 mg/kg) and Cl 72.4 ml/(h.kg), respectively. The approximate values of the individual doses (D) were calculated according to equation D = Dp.Cp/Ci, where Ci is the individual drug serum concentration 1, 3 or 6 h after administration and Cp is the corresponded population value (4.8, 1.9 and 0.8 mg/l, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.forename: A A
authors.initials: AA
authors.lastname: Firsov
authors.forename: M E
authors.initials: ME
authors.lastname: Alekseeva
authors.forename: G I
authors.initials: GI
authors.lastname: Lukomskiĭ
authors.forename: L V
authors.initials: LV
authors.lastname: Umnova
authors.forename: L B
authors.initials: LB
authors.lastname: Kashina
mesh_terms: D001682:Biological Availability; D016903:Drug Monitoring / Q000379:methods*; D005839:Gentamicins / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy* / Q000378:metabolism; D012853:Sisomicin / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics; D013997:Time Factors
chemical_list: D005839:Gentamicins; D012853:Sisomicin
vernacular_title: Farmakokineticheskiĭ monitoring pri lechenii aminoglikozidami: optimal'nyĭ sposob individualizatsii dozirovaniia gentamitsina i sizomitsina.